| abstract |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to chemical-pharmaceutical industry, and concerns a pharmaceutical neuroprotective and antioxidant composition containing 100-250 mg of 3-oxipyridine or its pharmaceutically acceptable derivative, or pharmaceutically acceptable salt of this derivative, 400-500 mg of pharmaceutically acceptable magnesium derivative and 10-50 mg of pyridoxine or its pharmaceutically acceptable derivative, and additionally, it contains 10-50 mg of nicotinamide and 15-30 mg of a substance chosen from idebenone or ubiquinone (coenzyme Q10), and the method of treatment and/or prevention of neurotic and pseudoneurotic conditions, conditions associated with oxidative stress, organic psychosyndrome caused by disturbed cerebral circulation, discirculatory encephalopathy, craniocerebral injury, various intellectual mnestic disorders, abstinence syndrome, acute disturbed cerebral circulation, intoxications caused by antibiotics that involves introduction of the pharmaceutical composition under the invention in therapeutically effective amount to an indigent individual. ^ EFFECT: more expressed synergism of components ensured in comparison with a prototype. ^ 8 cl, 4 ex |